Alert: Canvas Outage Update
Canvas access has been restored for our users, but the service reliability remains uncertain. Due to recent events, Canvas has had intermittent outages which are at the discretion of the vendor and may occur during a final exam. Faculty and staff may continue to use Canvas, but we strongly advise faculty and students to prepare a contingency plan for turning in assignments and final exams in the event Canvas access becomes unavailable again.
Instructure, the company that owns Canvas, has provided an FAQ about the incident, which may not answer all your questions. We will share more information if it becomes available.
Instructure, the company that owns Canvas, has provided an FAQ about the incident, which may not answer all your questions. We will share more information if it becomes available.
Learn More
Department News
-
First of its Kind Study Identifies Metabolic Defects in Dravet Syndrome
Mar 24, 2025New research from Manisha Patel, PhD, is the first to identify defects related to metabolism (how the body processes and uses energy) in lymphoblast cell lines (LCLs) derived from blood samples of children with Dravet syndrome.Full story -
Nanomedicine–lipoprotein interactionsOpens in a new window
Feb 26, 2025Nanomedicines interact with lipoproteins in the blood, which might result in alterations in both nanomedicine and lipoprotein structure and function. Such interactions could also be exploited for site-specific delivery through a ‘lipoprotein Trojan Horse’ mechanism and to restore dysfunctional lipoproteins.Opens in a new window Full story -
Small Molecule Modulators of AMP-Activated Protein Kinase (AMPK) Activity and Their Potential in Cancer TherapyOpens in a new window
Jan 29, 2025Philip Reigan, PhD, published new research in the Journal of Medicinal Chemistry. “Small Molecule Modulators of AMP-Activated Protein Kinase (AMPK) Activity and Their Potential in Cancer Therapy” provides an overview of the role of AMPK in cancer and the development of small molecule modulators of AMPK activity and summarizes the indirect and direct AMPK activators and emergent AMPK inhibitors and the challenges of developing these agents as therapeutics.Opens in a new window Full story -
Exploiting an immune response to alter the side effects of cancer treatmentOpens in a new window
Jan 25, 2025Drs. Anchordoquy, Simberg, Tilden, and Ricco talked to #Futurum about their work reducing the damage to healthy cells caused by chemotherapy. This group of scientists hopes to make cancer treatment more targeted, effective, and tolerable for all patients.Opens in a new window Full story -
New Study Uncovers Key Insights Into Protein Interactions in Duchenne Muscular Dystrophy, Paving Way for More Targeted TherapiesOpens in a new window
Dec 31, 2024A groundbreaking study has shed light on the complex interactions between dystrophin, a protein critical to muscle stability, and its partner protein, dystrobrevin, offering new pathways for understanding and treating Duchenne Muscular Dystrophy (DMD).Opens in a new window Full story -
Research Retreat Returns to the Rocky Mountains
Aug 7, 2024The Skaggs School of Pharmacy and Pharmaceutical Sciences (CU Pharmacy) Research Retreat returned to the Rockies for the first time since 2019.Full story -
The Center for Drug Discovery Brings Biotechnology to the Rocky MountainsOpens in a new window
May 13, 2024Aurora, Denver’s biggest suburb, is the epicenter of life sciences research: a 256-acre complex that’s home to the University of Colorado’s Anschutz Medical Campus, which receives $700 million in annual grant funding. Dan LaBarbera, PhD, is a professor of pharmaceutical sciences and founding director of the CU Skaggs School of Pharmacy and Pharmaceutical Sciences' Center for Drug Discovery.Opens in a new window Full story -
Lampe Team Garners $6.2 Million in Grants to Support Antibiotic and Drug Toxicity ResearchOpens in a new window
Apr 2, 2024The work of the Lampe Lab has recently been acknowledged by the National Institutes of Health (NIH) with two new R01 project grants totaling a combined $6.2 million.Opens in a new window Full story -
Pioneering Work on Campus Personalizes Prescription Drug TreatmentOpens in a new window
May 17, 2022Researchers and clinicians on campus are transforming the way medications are prescribed for patients. A CU pharmacy expert talks about how and why the scientists are tailoring prescriptions using patient genetics.Opens in a new window Full story -
Newly developed drug shows promise against a novel oncogene that supports cancer progressionOpens in a new window
Apr 7, 2022In findings recently published in the Journal of Medicinal Chemistry, Daniel LaBarbera, PhD and colleagues describe the optimization of the first lead CHD1L inhibitors (CHD1Li) through drug design and medicinal chemistry.Opens in a new window Full story -
Drug Developed in CU Lab Shows Promise Against a Novel Oncogene that Supports Cancer ProgressionOpens in a new window
Apr 4, 2022An enzyme instrumental in many types of cancer progression is meeting its match in inhibitors synthesized and evaluated by CU Cancer Center researchers.Opens in a new window Full story -
Medicago's first of its kind plant-based COVID-19 vaccine authorized in CanadaOpens in a new window
Mar 1, 2022David Kroll, PhD discusses the use of plant-based products for vaccines on the heels of the approval of the newest COVID-19 vaccine authorization in Canada.Opens in a new window Full story -
Eight Things You Should Know About Omicron
Jan 11, 2022Omicron cases are rising at staggering rates worldwide, and Colorado, once again, stands out as a national hotspot. But what does this latest SARS-CoV-2 variant carrying a whopping 50 mutations really mean? CU experts try to answer some of those questions as the world of COVID turns.Full story -
P4’S Research Lands her National Fellowship and Faculty Admiration
Jan 10, 2022P4 Madison Ricco combines her love of research with clinical practice, and won a Gateway to Research Award in the process.Full story -
New Research Could Anticipate Covid’s Next Move
Jan 10, 2022Dr. Krishna Mallela and his team are working to identify new COVID-19 variants, before the virus can mutate itself.Full story -
Study highlights importance of positive and negative selection in evolution of SARS-CoV-2 variants news outletOpens in a new window
Dec 28, 2021Krishna Mallela, PhD, and his team received press coverage for the lab’s work on SARS-CoV-2 variants, which focused on the study which highlights the importance of positive and negative selection in evolution of SARS-CoV-2 variants.Opens in a new window Full story -
Covid pills are ‘very promising’ – but what are the challenges in using them?Opens in a new window
Dec 28, 2021Peter Anderson, PharmD spoke with the Guardian about Paxlovid and molnupiravir, which were authorized by the FDA recently. Supplies of Paxlovid are limited while molnupiravir is less effective than hoped, but they are a very important step forward.Opens in a new window Full story -
How the 2 New Pills for Treating COVID-19 Stack Up: Here's What Experts SayOpens in a new window
Dec 28, 2021Both Pfizer’s Paxlovid and Merck’s molnupiravir are cleared for emergency use in non-hospitalized people who have mild-to-moderate symptoms and are at heightened risk of developing severe disease. Peter Anderson, PharmD spoke with Health regarding their effectiveness.Opens in a new window Full story -
Patel Elected First Vice President of American Epilepsy Society
Dec 13, 2021Manisha N. Patel, PhD, has been installed as First Vice President of the American Epilepsy Society (AES), a medical and scientific professional society with 4,500 members. Dr. Patel’s term started at the end of the society’s annual meeting, held in Chicago December 3-7, 2021. She will serve in the society’s presidential line and begin her term as president in 2023.Full story -
CU Professor Gives Hand and Heart to HeLa Legacy: Medicine’s Gift Ungiven
Nov 12, 2021Many people know the story of Henrietta Lacks, whose cancer cells, unknowingly taken from her 70 years ago, changed medical research. But few know the tale like CU Pharmacy Professor David Kroll, who used those cells as a graduate student and continues to pay tribute to the woman’s legacy today.Full story